The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Convertible and in Medtech.
At Longaeva Partners, we adapt to evolving markets through deep research and forward-thinking insights.
Venture capitalNew York, USAlongaeva.comRounds from 2025-09-03 to 2026-09-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nscale Nscale full-stack AI cloud platform and services are designed for scale, resilience, and speed. | Convertible Verified against 1 of 17 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.4B | 2026-09-25 | [ PART ] |
Convertible Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $100M |
| 2026-03-19 |
| [ PART ] |
Galvanize Therapeutics Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-09-03 | [ PART ] |